EGFR and neoplasm: It has been widely found that epidermal growth factor receptor (EGFR) signaling is deregulated in NSCLC, and EGFR activation was demonstrated to be associated with multiple biological responses in tumor cells, including driving uncontrolled proliferation, conferring evasion of programmed cell death, and enhancing migration and metastasis [1, 8, 9].